Back to Search
Start Over
CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients.
- Source :
-
European neurology [Eur Neurol] 2022; Vol. 85 (1), pp. 69-71. Date of Electronic Publication: 2021 Aug 02. - Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 1421-9913
- Volume :
- 85
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- European neurology
- Publication Type :
- Report
- Accession number :
- 34340233
- Full Text :
- https://doi.org/10.1159/000517770